According to the 2016 definitions of the WHO and the European Organization for Research and Treatment of Cancer (EORTC), primary cutaneous CD30 lymphoproliferative disorders include pc-ALCL, lymphomatoid papulosis (LyP), and borderline lesions [93,94]. This evidence concerns the gene TNFRSF8 and cancer.